Wei Li – Global Chief Investment strategist together with Bruno Rovelli Chief Investment Strategist for Italy and Natalie Gill – Portfolio Strategist, all forming part of the BlackRock Investment Institute and Carrie King – Global Chief Investment Officer, Fundamental Equities of BlackRock share their insights on global economy, markets and geopolitics. Their views are theirs alone and are not intended to be construed as investment advice.
Key Points
More resilience : U.S. corporate earnings strength is broadening. Earnings resilience and mega forces like AI keep us overweight U.S. stocks.
Market backdrop : The S&P 500 kicked off the new year on a positive note to reach a record high. U.S. Treasury yields were steady, while gold pushed back near all-time highs.
Week ahead : The December U.S. CPI will provide a clean read of the inflation picture after the government shutdown disruptions.
Solid U.S. economic growth and Federal Reserve rate cuts have boosted corporate earnings and profit margins, lifting U.S. stocks and underpinning our overweight. We think this will keep playing out in Q4 earnings results starting this week. We see three themes: a further narrowing of the earnings gap between the “magnificent seven” stocks and other sectors; mega forces supporting cyclical sectors; and AI-led productivity gains potentially offsetting typical earnings downgrades.
The U.S. corporate earnings season is key after the S&P 500 posted a third straight year of double-digit returns in 2025, while international markets from Spain to South Korea also delivered strong results. The AI buildout and easing tariff concerns kept economic growth resilient, helping U.S. earnings beat expectations in the third quarter, as we expected. We think earnings can keep delivering, partly as the U.S. stocks driving earnings growth broaden out. The gap between the magnificent seven mega cap stocks like Nvidia and the rest of the S&P 500 is narrowing as the other 493 see earnings improve – the first theme we’re watching. See the chart. Yet the magnificent seven are still delivering strong earnings growth – and have consistently beat expectations in recent years, according to Bloomberg data, so that gap may not narrow as much as the consensus implies.
We still prefer tech broadly as earnings growth looks healthy and poised to broaden, both within the U.S. and globally. S&P earnings and profit margins have also proved more resilient to tariffs than many investors expected. Consensus expectations for the magnificent seven have been revised upward to show 20% earnings growth in the fourth- quarter versus a year ago and then holding up at 19% in 2026, according to Bloomberg data. That compares with 6% for the other S&P 493 in the fourth-quarter and 15% in 2026. Such earnings strength is why U.S. tech stocks depended less on investors pricing in higher valuations for gains last year relative to Europe and other regions. From the U.S. “reciprocal tariff” lows in April, the MSCI USA slightly outperformed the MSCI index of global stocks excluding the U.S. in 2025 and outperformed the same index in local currency terms by six percentage points, according to LSEG data.
Powerful mega forces can trump the macro
Second, mega forces and lower Fed policy rates are helping boost cyclical sectors linked to stronger growth, like industrials and materials. This reinforces how we are not in a typical business cycle and mega forces are trumping the traditional macro in driving returns – one of our 2026 Global Outlook themes. Sectors including industrials and materials sit at the intersection of these mega forces: the construction and energy required in the AI data center buildout; the power grid upgrades and infrastructure investment in the energy transition; and increased defense spending tied to geopolitical fragmentation.
Our third theme: Potential productivity gains from AI could break the usual pattern of earnings estimates typically starting high and being revised down as the year progresses. We like financials in both the U.S. and Europe, with the U.S. benefitting from stronger dealmaking activity and lighter regulation. We find that financials is one of the sectors talking the most about AI productivity benefits in earnings calls. The healthcare sector is a laggard that we think is ripe for potential productivity improvements and innovation, with 80% of U.S. healthcare companies guiding earnings expectations higher, FactSet data show. We’re closely watching earnings for evidence of AI-related productivity gains and new profit pools forming.
Our bottom line
We stay overweight U.S. equities and pro-risk on the AI theme. We eye opportunities in sectors beyond tech like healthcare that benefit from AI innovation and see mega forces supporting some key cyclical sectors like industrials.
Market backdrop
The S&P 500 advanced nearly 2% to a fresh record high in the first full trading week of 2026 while European stocks outperformed. The U.S. December jobs report reinforced our view of a “no hiring, no firing” stasis in the labor market. Yet renewed wage gains could point to sticky inflation that will curb how soon the Fed might cut rates again. U.S. 10-year Treasury yields stayed in a tight range around 4.15%. Gold jumped more than 4% back to near record highs.
Attention turns to the U.S. CPI after recent U.S. data proved noisy, owing to disruptions from the government shutdown. November U.S. CPI reflected partially collected data, and no data was collected for October – making this week’s December CPI report and the following releases clearer signals for assessing inflation. Early-year CPI has been strong in recent years, so inflation could surprise to the upside and curb expectations for Fed rate cuts.
Week Ahead
Jan. 12-19 : China total social financing
Jan. 13 : U.S. CPI; China trade
Jan. 14 : U.S. PPI
Jan. 15 : UK November GDP; U.S. Philly Fed manufacturing; U.S. trade
BlackRock’s Key risks & Disclaimers:
This material is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of 12th January, 2026 and may change. The information and opinions are derived from proprietary and non-proprietary sources deemed by BlackRock to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by BlackRock, its officers, employees or agents. This material may contain ’forward looking’ information that is not purely historical in nature. Such information may include, among other things, projections and forecasts. There is no guarantee that any forecasts made will come to pass. Reliance upon information in this material is at the sole discretion of the reader.
The information provided here is neither tax nor legal advice. Investors should speak to their tax professional for specific information regarding their tax situation. Investment involves risk including possible loss of principal. International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation, and the possibility of substantial volatility due to adverse political, economic or other developments. These risks are often heightened for investments in emerging/developing markets or smaller capital markets.
Issued by BlackRock Investment Management (UK) Limited, authorized and regulated by the Financial Conduct Authority. Registered office: 12 Throgmorton Avenue, London, EC2N 2DL.
MeDirect Disclaimers:
This information has been accurately reproduced, as received from BlackRock Investment Management (UK) Limited. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.
The financial instruments discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.
If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.
